iBio nimmt an drei Investorenkonferenzen teil
- iBio nimmt vom 9. bis 11. November 2026 an der Guggenheim Healthcare Innovation Conference in Boston teil.
- Vom 16. bis 19. November 2026 folgen Einzelgespräche auf der Jefferies Global Healthcare Conference in London.
- Die Teilnahme an der Piper Sandler 38th Annual Healthcare Conference in New York ist vom 1. bis 3. Dezember 2026 vorgesehen.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iBio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021630PRIMZONEFULLFEED9868376) on November 02, 2026, and is solely responsible for the information contained therein.